TMEM194A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.259450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.375600E-01
Normal-vs-Stage2
1.666150E-01
Normal-vs-Stage3
2.442800E-01
Normal-vs-Stage4
2.525800E-01
Stage1-vs-Stage2
9.316600E-01
Stage1-vs-Stage3
1.255960E-02
Stage1-vs-Stage4
2.911000E-01
Stage2-vs-Stage3
1.64601665630926E-12
Stage2-vs-Stage4
4.330400E-01
Stage3-vs-Stage4
2.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.648000E-01
Normal-vs-AfricanAmerican
3.932600E-01
Normal-vs-Asian
3.369600E-01
Caucasian-vs-AfricanAmerican
4.318800E-01
Caucasian-vs-Asian
1.049980E-01
AfricanAmerican-vs-Asian
5.581000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.837000E-01
Normal-vs-Female
2.141200E-01
Male-vs-Female
7.603600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.846400E-01
Normal-vs-Age(41-60Yrs)
4.554400E-01
Normal-vs-Age(61-80Yrs)
4.335800E-01
Normal-vs-Age(81-100Yrs)
3.864400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.911200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.038000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.477400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.742500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.274000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.454400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.554170E-01
Normal-vs-Daily Drinker
4.103600E-01
Normal-vs-Weekly Drinker
1.234840E-01
Normal-vs-Occasional Drinker
5.430200E-01
Normal-vs-Social Drinker
5.686600E-01
Non Drinker-vs-Daily Drinker
8.627400E-01
Non Drinker-vs-Weekly Drinker
8.898400E-01
Non Drinker-vs-Occasional Drinker
2.457800E-01
Non Drinker-vs-Social Drinker
2.327800E-01
Daily Drinker-vs-Weekly Drinker
9.915000E-01
Daily Drinker-vs-Occasional Drinker
2.101000E-01
Daily Drinker-vs-Social Drinker
1.181420E-01
Weekly Drinker-vs-Occasional Drinker
2.785600E-01
Weekly Drinker-vs-Social Drinker
2.042800E-01
Occasional Drinker-vs-Social Drinker
7.585000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.498400E-01
Normal-vs-Grade 2
8.620000E-01
Normal-vs-Grade 3
9.278400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.965600E-01
Grade 1-vs-Grade 3
1.133150E-01
Grade 1-vs-Grade 4
8.498400E-01
Grade 2-vs-Grade 3
8.294200E-02
Grade 2-vs-Grade 4
8.620000E-01
Grade 3-vs-Grade 4
9.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.225400E-01
Normal-vs-NonDiabetic
1.476800E-01
Diabetic-vs-NonDiabetic
2.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.960600E-01
Normal-vs-NoPancreatitis
1.209010E-01
Pancreatitis-vs-NoPancreatitis
7.294400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.372800E-01
Normal-vs-N1
1.942810E-01
N0-vs-N1
1.592410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.702200E-01
Normal-vs-TP53-NonMutant
5.195600E-01
TP53-Mutant-vs-TP53-NonMutant
9.859700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
